CLSA On Aurobindo Maintain Buy, TP raised to Rs 920 from Rs 790Strong All-around PerformanceLaunch Momentum In US & EU Remains StrongResults Well Ahead Of EstVolume Share Gains In US & Stocking Benefit In EU Drove Margin#AUROPHARMA